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The formation of the nervous system during embryonic development is controlled by a complex network of
signaling pathways which ensure proper migration and targeting of neuronal projections. Likewise, the func-
tion of the adult nervous system relies on complex dynamic interactions between the presynaptic and post-
synaptic terminals. Here, we review recent advances in understanding the molecular pathways underlying
these seemingly distinct processes. These studies reveal that the conserved E3 ubiquitin ligase PHR
(PAM, highwire Rpm-1) controls a regulatory protein degradation pathway essential both for axonal targeting
during embryonic development as well as for the proper formation and function of neuronmuscular junctions
(NMJ).Introduction
The nervous system is a complex network of axonal projections
and synaptic connections. Advances in understanding the devel-
opment and function of the nervous system in different organisms
show that a limited yet well-conserved arsenal of molecular tools
and pathways are used repeatedly both to guide axons toward
targets and to build functional synapses—two apparently distinct
aspects of neuronal cell biology. This raises interesting ques-
tions: how are these components regulated, and, are the regula-
tory strategies distinct in different developmental stages, cell
types or subcellular locations? Among the most ancient and con-
served mechanisms to control biological processes are those
that mediate the production or elimination of proteins. Although
such cellular machinery was often considered primarily house-
keeping in its nature, work in recent years has helped us to appre-
ciate that the regulation of protein synthesis and degradation play
important roles in the fine-tuning of neuronal architecture. An
excellent example among molecules that control neuronal pro-
teosome-dependent protein degradation is the PHR family of
E3-ubiquitin ligases encoded by the genes PAM (mouse), high-
wire (Drosophila), rpm-1 (C. elegans), and esrom (zebrafish). First
identified as modulators of synapse biology in flies and worms
(Chang and Balice-Gordon, 2000), genetic analyses in verte-
brates now reveal not only conservation in PHR synaptic function,
but also vital roles for these proteins early in development as
axons seek out specific target cells (Bloom et al., 2007; Hendricks
et al., 2007; Lewcock et al., 2007).
PHR Proteins—Critical Regulators of Synaptic
Growth and Function
DrosophilaHighwire and itsC. elegans ortholog Rpm-1 were dis-
covered concurrently using forward genetic screens (Wan et al.,
2000; Zhen et al., 2000; Schaefer et al., 2000). In Drosophila,
highwire (hiw) was identified during a behavioral screen of the
X chromosome designed to detect locomotor mutants, followed
by an anatomical screen of the larval neuron muscular junction
(NMJ) (Wan et al., 2000). The gene encodes a high-molecular
weight protein that was localized around the perimeter of the ac-tive zone (Wan et al., 2000), the synaptic cytomatrix responsible
for vesicle docking and neurotransmitter release, though this dis-
crete ‘‘periactive zone’’ distribution was challenged when a later
study revealed the antibody to be nonspecific (Wu et al., 2005).
Drosophila hiw mutants are characterized by synaptic over-
growth consisting of extensive branching of the terminal arbor
and an expanded number of presynaptic varicosities (‘‘boutons’’)
at the NMJ. Interestingly, while these expanded synapses are
functional they display reduced quantal content compared to
wild-type. The aberrant synaptic sprouting of Drosophila NMJs
is not unique to hiw mutants. For example, a 50% reduction in
the levels of cell adhesion molecule Fas II, a protein known to
control synaptic growth and stabilization, induces a synaptic
phenotype similar to the one observed in hiw mutants (Schuster
et al., 1996). For many years, it was thought that the functions
of the presynaptic terminal are restricted to the active zone itself
(Landis et al., 1988). However, the localization of Fas II and other
synaptic proteins to the surrounding periactive zone led re-
searchers to propose that this understudied region of presynap-
tic membrane plays an important role in the growth and stabiliza-
tion of the presynaptic terminal (Sone et al., 1997).
Two independent studies identified the function of the C. ele-
gans homolog of highwire, Rpm-1, in regulating neuronal mor-
phology (Schaefer et al., 2000) and the organization of presynap-
tic terminals at GABAergic NMJs (Zhen et al., 2000). Studies
using Rpm-1:GFP fusion proteins and Rpm-1 antibodies re-
vealed that Rpm-1 is localized at the presynaptic terminals and
preferentially distributed in the periactive zone regions (Zhen
et al., 2000; Liao et al., 2004). Two NMJ phenotypes were ob-
served in C. elegans rpm-1 mutants: in some NMJs there were
a reduced number of enlarged presynaptic terminals with multi-
ple active zones, whereas in others the presynaptic terminals ap-
peared to be underdeveloped or absent. Although hiw and rpm-1
mutant phenotypes seem to be different, the inconsistency
might be explained by contrasting NMJ morphology in flies
and worms; unlike Drosophila, the C. elegans NMJ does not
branch over the postsynaptic muscle field (White et al., 1976). In-
terestingly, analysis of several different classes of neuronsNeuron 57, February 7, 2008 ª2008 Elsevier Inc. 339
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ent types of neurons. For example, the mechanosensory neu-
rons in rpm-1mutant worms display ectopic branching, targeting
defects, and fail to establish synapses (Schaefer et al., 2000;
Zhen et al., 2000), more reminiscent of the hiw defects in Dro-
sophila. Similar to Drosophila and C. elegans, the murine ortho-
log of hiw, Phr1, acts in motorneurons in a cell-autonomous
manner to control the development of NMJ (Burgess et al.,
2004) (Bloom et al., 2007).
Highwire Mediates Ubiquitin-Dependent Protein
Degradation at the Synapse
The role of hiw and rpm-1 in negatively regulating synapse devel-
opment raised the challenge to identify the underlying molecular
mechanisms. Several different functional motifs displaying a high
degree of conservation across species were mapped on the PHR
proteins PAM, Hiw, and Rpm-1 (Guo et al., 1998; Wan et al., 2000;
Zhen et al., 2000; Schaefer et al., 2000). One domain received
particular attention: the cysteine-rich C-terminal region which
contains a RING-H2 type zinc finger motif characteristic of
many E3 ubiquitin ligases. This domain was shown to be essential
for the Hiw-mediated regulation of synaptic growth and function
inDrosophila (Wu et al., 2005), leading to the hypothesis that PHR
proteins control synaptic morphogenesis and plasticity by induc-
ing proteasome-dependent protein degradation of presynaptic
substrates. The first support for this model came from an elegant
genetic study by DiAntonio and colleagues that examined the role
of ubiquitin-dependent proteolysis at the Drosophila NMJ (DiA-
ntonio et al., 2001; reviewed by Fischer and Overstreet, 2002). Di-
Antonio and colleagues discovered that panneural over-
expression of the Drosophila deubiqitinating protease gene fat
facets (faf) (Huang et al., 1995) or its yeast ortholog UBP2 caused
an increase in the number of synaptic boutons and abnormal
sprouting of presynaptic branches. However, this increase in
synaptic growth was accompanied by a concomitant decrease
in the presynaptic quantal content, reminiscent of the defects
in hiw mutants. Moreover, a genetic interaction screen to dis-
cover the molecular pathways downstream of faf identified hiw
as a strong enhancer of faf overexpression. A closer analysis
of this genetic interaction showed that while loss of faf alone
does not cause any defects in synaptic morphology or function,
likely due to the redundancy of other deubiquitinating enzymes,
faf loss of function (LOF) is a genetic suppressor of hiw. Interest-
ingly, this effect is specific to the neurotransmitter release mech-
anisms, as faf did not rescue the hiw synaptic overgrowth pheno-
type. This study established that ubiquitin-dependent protein
degradation pathways represent an important component of
the mechanism regulating synaptic function but also raised the
question of what regulatory controls might lie upstream and
what targets lie downstream of Hiw and its orthologs in other
species.
PHR Proteins Control Multiple Signaling Pathways
in Flies and Worms
The first candidate target of Hiw in Drosophila was the Smad
transcription factor Medea (Med) that mediates a presynaptic
bone morphogenic protein (BMP) signaling cascade at the
NMJ (McCabe et al., 2004). Three BMP receptors, Wit, Thv,340 Neuron 57, February 7, 2008 ª2008 Elsevier Inc.and Sax, localized in the presynaptic terminal, have been shown
to initiate a retrograde signaling cascade activated by BMP li-
gands secreted from the postsynaptic terminal (Keshishian and
Kim, 2004). Med mediates transcriptional regulation down-
stream of these receptors to regulate the concerted growth of
the presynaptic and postsynaptic terminals (McCabe et al.,
2004). McCabe and colleagues proposed that this pathway is
under a tight negative regulatory control exerted by Hiw via an
ubiquitination-dependent mechanism. Biochemical and genetic
evidence supported this hypothesis. Hiw was shown to bind
Med directly, as indicated by multiple protein-interaction assays.
Parallel genetic analysis also showed that loss of either Med or
Wit suppressed the increase in synaptic boutons observed in
hiw mutants. Panneural overexpression of a constitutively active
BMP receptor (Tkv) had no effect on synaptic growth in a wild-
type background; however, when overexpressed in a hiwmutant
background, it lead to a substantial increase in the number of
synaptic boutons even compared to hiwmutants alone (McCabe
et al., 2004).
These results were consistent with hiw negatively regulating
BMP signaling at the Drosophila NMJ. However, it was difficult
to provide clear evidence supporting the role of Hiw in mediat-
ing ubiquitin-dependent protein degradation of Med or other
components of the BMP signaling pathway. It remains possible
that the negative regulation of the BMP pathway exerted by the
interaction of Hiw with Med may occur via an ubiquitination-
independent mechanism. It is noteworthy that, except for the
effect of BMP genetic modifiers on the number of synaptic bou-
tons, other hiw mutant phenotypes, including the reduced indi-
vidual bouton size, aberrant NMJ sprouting, and the defects in
neurotransmitter release, are not responsive to these genetic
manipulations, suggesting that they occur independently of
BMP signaling. Moreover, a recent study revealed that the
levels of phospho-MAD, a major readout of BMP signaling in
Drosophila, are not altered in hiw mutants compared to control
animals (Collins et al., 2006). This observation suggests that, at
the synapse, Hiw and BMP signaling cascades are parallel
pathways. Thus, the function of Hiw in controlling synaptic
growth and function is likely to involve interactions with yet other
partners.
Strong evidence for a direct downstream target of PHR-family
proteins came from studies inC. elegans (Liao et al., 2004). A ge-
netic screen for modifiers of locomotion defects inC. elegans led
to the discovery of a novel F box protein, Fsn-1. Mutants null for
fsn-1 displayed phenotypes which resembled those observed in
rpm-1 mutants, characterized by the simultaneous presence of
overdeveloped and underdeveloped NMJs. Moreover, Fsn-1
was preferentially localized at periactive zones, overlapping
Rpm-1 distribution. F box proteins function as substrate re-
cognition subunits for a multiprotein ubiquitin-ligase complex
generically know as SCF (Skp/Cullin/F box) (Deshaies, 1999). A
biochemical coimmunoprecipitation showed that C. elegans
Fsn-1 can associate specifically with Rpm-1 (Liao et al., 2004),
a result that was also confirmed with the Drosophila orthologs
DFsn and highwire (Wu et al., 2007). Both Fsn-1 and Rpm-1
also bind to Cul-1 and Skr-1, the C. elegans homologs of the
mammalian SCF complex subunits Cullin and Skp-1 (Liao et al.,
2004). The presence of Rpm-1 in this complex defined a novel
Neuron
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important role in regulating synaptic development in C. elegans.
Liao and colleagues attempted to find the direct downstream
targets of this Rpm-1-containing complex. They first identified
the C. elegans homolog of the mammalian receptor tyrosine ki-
nase ALK (Morris et al., 1997) as a direct binding partner of
Fsn-1 (Liao et al., 2004). Although variable in degree, a deletion
mutant of ALK significantly rescued the fsn-1 synaptic pheno-
types, suggesting that it is one of several Fsn-1 targets. How-
ever, definitive evidence came from the analysis of ALK dis-
tribution and protein levels in fsn-1 and rpm-1 null genetic
backgrounds. Both mutants showed a robust, ectopic ALK
staining in the presynaptic terminals outside of the active zone
where endogenous ALK is normally localized, as well as up to
a 4-fold increase in ALK protein levels as seen in western blot
analysis. ALK therefore became the first synaptic protein whose
spatial distribution and levels were clearly under the control from
the Rpm-1/Fsn-1 ubiquitination complex. However, the partial
genetic rescue of Rpm-1 phenotypes as well as the broader
spectrum of synaptic defects in Rpm-1 mutants suggests that
ALK is only one of multiple Rpm-1 targets.
Dual Leucine-Zipper Kinases: Conserved
Targets of PHR Ubiquitin Ligases
Following the identification of ALK as an Rpm-1 target, two inde-
pendent studies identified another pathway directly regulated by
Hiw/Rpm-1 and conserved in both C. elegans (Nakata et al.,
2005) and Drosophila (Collins et al., 2006). Using forward genetic
screens, both studies uncovered components of the mixed line-
age subfamily of the dual leucine-zipper-bearing kinases (DLK)
(Gallo and Johnson, 2002) as strong suppressors of rpm-1 and
hiw synaptic phenotypes. In C. elegans, the closest homolog
of this MAPKKK family is DLK-1. The study by Nakata and col-
leagues revealed that synaptic DLK-1 is the most upstream com-
ponent of a C. elegans MAP kinase pathway that includes the
downstream MAPKK, MKK-4, and the p38-like kinase PMK-3
(Berman et al., 2001). While the synaptic function of this pathway
may be redundant with other MAPK pathways (LOF mutations of
these kinases have very subtle effects of synaptic development
and function), limiting the activity of its components seems to be
critical. When components of this pathway were overexpressed
in neurons, severe cell-autonomous synaptic phenotypes identi-
cal to those seen in rpm-1 mutant animals were generated. In
conjunction with the ability of LOF mutations of Dlk-1, MKK-4
and PMK-3 to suppress rpm-1 phenotypes, these findings indi-
cated that rpm-1 keeps the DLK MAP kinase cascade in check at
the synapse. This notion was further supported by two other ob-
servations: first, Dlk-1 and Rpm-1 both localize to the periactive
zone of the presynaptic terminal, and second, Rpm-1 directly
controls the stability and levels of Dlk-1 at the synapse, as re-
vealed by an increase in the levels of Dlk-1 in Rpm-1 mutants
in vivo and by the ability of Rpm-1 RING finger domain to directly
ubiquitinate Dlk-1 in cultured cells. All together, these findings
indicate that in C. elegans, the inhibition of Dlk MAP kinase
pathway by Rpm-1 represents a critical event in the regulation
of synaptic development and function (Figure 1).
A similar forward genetic approach for suppressors of hiw-
mediated synaptic growth defects led to the identification of Wal-lenda, the closest Drosophila homolog of the mammalian Dlk-1
MAPKKK (Collins et al., 2006). Consistent with the observations
in C. elegans, Wallenda protein localizes to the synaptic termi-
nals, and its cellular levels in the larval ventral nerve cord neuropil
are tightly controlled by hiw-dependent ubiquitin-mediated
protein degradation. Studies showed that overexpression of
ubiquitin hydrolases substantially increases the levels of Wal-
lenda protein in the neuropil. Similar increases were observed
in both endogenous and transgenic Wallenda protein levels in
hiwmutants. As in the case of Dlk-1, overexpression of Wallenda
resulted in phenotypes reminiscent of hiw mutants. However, in
contrast to C. elegans, a surprising discrepancy was reported
with respect to the downstream MAPKKK components regulat-
ing synaptic growth. InC. elegans, the most downstream effector
of Dlk-1 was the p38-like kinase PMK-3. Drosophila has two p38
genes, p38a and p38b, but, inhibiting both of these genes did not
suppress the hiw synaptic growth phenotype. Instead, the sig-
naling cascade downstream of Wallenda seemed to involve the
JNK kinase and the transcription factor D-Fos. Both the hiw
LOF and the Wallenda gain-of-function (GOF) synaptic pheno-
types were suppressed by a dominant-negative JNK construct
or a dominant-negative form of D-Fos. It is noteworthy that while
not tested in C. elegans, one of the best-studied downstream ef-
fectors of mammalian MAPKK MKK-4 is JNK. Given the compa-
rable effects of Dlk-1 and MKK-4 at theC. elegans synapse, it re-
mains possible that the JNK pathway also functions downstream
of Rpm-1 in worms. The action of PHR ubiquitin ligases on the
upstream governors of this synaptic MAP kinase pathway
provides an elegant strategy to ensure proper spatiotemporal
regulation and avoid pleiotropic effects that might result from tar-
geting downstream effectors shared by other signaling pathways
(Figure 1).
Of course, life is never that simple. Recent studies in C. ele-
gans also reveal that Rpm-1 performs ubiquitin ligase-indepen-
dent functions via the Rab guanine nucleotide exchange factor
(GEF) GLO-4 to positively regulate the Rab GTPase GLO-1 (Grill
et al., 2007). GLO-4 and GLO-1 give Rpm-1 the ability to control
vesicular trafficking in mechanosensory neurons, suggesting
that PHR proteins may coordinate multiple aspects of synaptic
cell biology. Other PHR targets include tuberous sclerosis com-
plex (TSC) signaling (D’Souza et al., 2005; Murthy et al., 2004),
myc activity (Guo et al., 1998), and cAMP metabolism via the in-
hibition of adenylate cyclase (Pierre et al., 2004); however, the
contributions of these targets to the function of PHR in synaptic
development have yet to be explored.
PHR Proteins—Regulators of CNS Axonal Growth
and Pathfinding
Although PHR proteins are well appreciated as regulators of syn-
aptic form and function, papers published in the last few months
reveal that they also control the long-range guidance of axons to
reach synaptic partners. In a courageous leap from insect to
mammals, DiAntonio and colleagues showed that murine Phr1
mutants display severe axonal targeting defects throughout the
CNS (Bloom et al., 2007). Although Wallenda/DLK is a key target
of Hiw/Rpm-1 during worm and fly synapse formation (Nakata
et al., 2005; Collins et al., 2006), the subcellular localization
and the overall protein levels of neuronal DLK did not appearNeuron 57, February 7, 2008 ª2008 Elsevier Inc. 341
Neuron
MinireviewFigure 1. PHR Ubiquitin Ligases Control Synaptic Development and Function
(A) A Drosophila neuromuscular junction (NMJ): motor axons (red) decorated with presynaptic varicosities (‘‘boutons’’; see box) branch over the muscle target
field.
(B) Magnification of a presynaptic terminal in box in (A). At the interface with the muscle target, the presynaptic terminal assembles highly dynamic active zones
(black) responsible for vesicle trafficking and neurotransmitter release characterized by the presence of synaptic vesicles (yellow) and a dense, membrane-
associated protein network. Studies in C. elegans indicate that PHR ubiquitin ligases (green) localize to the areas surrounding the active zones known as the
periactive zone (orange). The conserved direct targets of these proteins appear to be the subfamily of dual leucine-zipper kinases (DLK) (red structures), repre-
sented by Dlk-1 in C. elegans and Wallenda in Drosophila. PHR proteins interact with and target DLK kinases for ubiquitin-dependent protein degradation, thus
fine-tuning a MAP kinase signal transduction pathway which inC. elegans involves the downstream MAPKK MKK-4 (blue) and the MAP kinase PMK3 (orange). In
Drosophila, the downstream effectors of the MAPKKK Wallenda appear to be different and comprise the JNK kinase (blue) and the transcription factor D-Fos
(red). Despite the discrepancy regarding the downstream effector pathways, maintaining the balance between the activation and inhibition of DLK kinases appear
to be essential for the normal NMJ formation and function in both organisms.to change in Phr1 mutant mice. Moreover, DLK;Phr1 double mu-
tant mice failed to rescue the Phr1 induced CNS targeting phe-
notypes, suggesting that unlike the NMJ development, DLK is
not a major target of Phr1 during cortical axon tract formation. In-
terestingly, unlike Hiw/Rpm-1 function at fly and worm synapses,
Phr1 action during cortical axonogenesis is not cell autonomous
(Bloom et al., 2007). Whether this Phr1 mechanism involves cell-
cell interaction directly or whether it might reflect a cell-autono-
mous role in some early neuronal scaffold required as a substrate
for cortical axons remains unknown. Thus, although synaptic
PHR seems to act by a well-conserved mechanism, the logic
of Phr1 function during axon guidance is divergent, at least in
cortical axons.
More recently, a paper from Hendricks and colleagues re-
vealed that the zebrafish ortholog of Phr1, esrom, is required
for the guidance of commissural axons across the roof plate
(Hendricks et al., 2007). Esrom mutants display a highly pene-
trant yet specific midline crossing defect, characterized by the
complete absence of the habenular commissure. Interestingly,
while Esrom protein appears to be ubiquitously expressed in
neurons, the habenular adjacent posterior and anterior commis-
sures are not affected in esrom mutants. Thus, the study pro-
poses that Esrom controls a signaling pathway which is essential
for interpreting an intermediate choice point at the habenular
commissure.342 Neuron 57, February 7, 2008 ª2008 Elsevier Inc.Phr-1 Function in Peripheral Axons: Cytoskeletal
Dynamics and Compartmentalization of the Axon
In the November 21, 2007 issue of Neuron, the Pfaff laboratory
unveiled their discovery that mammalian Phr1 is required for
the growth and pathfinding of peripheral axons in the mouse em-
bryo (Lewcock et al., 2007). In an extraordinary tour de force, us-
ing high-resolution in vivo imaging, Lewcock and colleagues per-
formed a mouse mutagenesis screen to find genes that control
motor axon guidance and targeting. Two of the recovered lines
(named Magellan after the great explorer who failed to reach
his intended destination) corresponded to the mouse Phr1
gene (Burgess et al., 2004).
Mammalian motor neuron axon pathfinding is governed by
two major developmentally timed processes: first, motor neuron
identity is established by a combinatorial effect of multiple tran-
scription factors (Jessell and Sanes, 2000; Briscoe and Ericson,
2001; Shirasaki and Pfaff, 2002); and second, several axon-
guidance pathways, including certain secreted semaphorins
(Huber et al., 2005) and the EphA4 (Kania and Jessell, 2003),
guide motor growth cones to the correct muscle masses.Magel-
lan mutants displayed a novel class of motor neuron defects ex-
emplified by wandering and stalling of axons at major choice
points along their route of passage. These phenotypes were
observed at different developmental time points as well as in dif-
ferent locations along the A-P axis: brachial segments, where
Neuron
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Adapted from Lewcock et al., (2007).
(A) In motor and sensory neurons, dual leucine-zipper kinases control microtubule stability via a signal-transduction pathway which involves the MAP kinase p38.
DLK activity is regulated by the mouse ortholog of Hiw, Phr1, which targets DLK for proteasomal degradation, thus precluding its ability to generate signals that
promote microtubule instability. The differential stability of the microtubule network in distinct axonal compartments is essential for the precise coordination be-
tween growth and pathfinding decisions. This appears to be controlled by the preferential localization of Phr1 to the axonal shaft where it presumably negatively
regulates DLK activity, thus promoting the formation of stable cytoskeletal structures. Conversely, the absence of Phr1 in the growth cone releases the signaling
pathways which promote dynamic instability of the cytoskeleton in this region.
(B) In wild-type animals, the growth cone is maintained at the distal tip of the axon during the growth and consolidation stages of axonal navigation. This process
appears to be facilitated by Phr1 (green), which binds to and stabilizes microtubules in the axonal shaft. In Phr1 mutant axons, DLK protein (red) appears to be
mislocalized and accumulates both in the growth cone as well as in the axonal shaft compartments. As a consequence, the distal growth cone is not properly
consolidated, and ectopic growth cones are formed along the axonal shaft, resulting in an overall decreased ability of the axons to properly navigate and respond
to guidance cues.aberrant projections from the ventral root extended into the dor-
sal root ganglia (DRG), lumbar levels, upper thoracic levels, and at
the crural plexus choice point of the hindlimb innervation. Analy-
sis of motor neuron markers showed that neuronal differentiation
and timing were normal inMagellanmice excluding the possibility
of a cell-fate defect as a cause for the observed phenotypes.
Similar to Drosophila and C. elegans, Phr1 is almost exclu-
sively expressed in the nervous system, and it accumulates in
embryonic motor and sensory neurons. Molecular analysis re-
vealed that the Magellan mutation results in a truncated form
of Phr1 which lacks the C-terminal ubiquitin ligase domain (Lew-
cock et al., 2007). Lewcock and colleagues next turned to
explore the molecular mechanism underlying the axonal pheno-
types in Phr1 mutants. Given the ability of PHR proteins to medi-
ate ubiquitin-dependent protein degradation, Phr1 could work to
regulate the levels and function of guidance receptors or their
downstream effectors. However, a comprehensive analysis us-
ing a variety of attractive and repulsive guidance pathways
(e.g., Eph, BDNF, NGF, and Sema3A pathways) revealed that
neither the levels of guidance receptors nor the ability of neurons
to respond to guidance cues in culture seemed to be affected in
Phr1 mutant mice. Thus, the usual suspects were not affected in
Phr1 mutant animals.Why then were Phr1 mutant neurons so severely disrupted?
The answer to this question came from time-lapse ex vivo imag-
ing studies. For these experiments, the authors described three
distinct stages during the growth of sensory and motor neuron
axonal processes: exploration, growth, and consolidation. These
stages were disrupted in Phr1 mutants, resulting in a lack of co-
ordination between axon shaft consolidation and growth cone
migration. Phr1 mutant axons displayed instability, often leading
to the formation of ectopic growth cones along the axon shaft
and a failure to maintain the polarized structure of the neurite.
Accordingly, the growth cone cytoskeleton—highly polarized in
normal growth cones—was severely disrupted in Phr1 neurons.
Microtubule orientation was abnormal during the exploration and
consolidation phases, as was microtubule penetration into the
growth cone’s actin-rich peripheral areas during the growth
phase. Consistent with these cytoskeletal abnormalities, Phr1
mutant axons display frequent bends and kinks as well as ec-
topic branching of the axonal shaft. Hence, the authors pro-
posed that Phr1 regulates cytoskeletal dynamics in developing
axons. Supporting this hypothesis, Phr1 protein was found to
be differentially distributed in neurites with most of the protein
localized to the axonal shaft and only low levels of protein
observed in the growth cones or distal processes. TheNeuron 57, February 7, 2008 ª2008 Elsevier Inc. 343
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of microtubule subpopulations: axonal shafts are rich in stable
microtubules composed of largely acetylated tubulin, while
growth cones contain mainly tyrosinated microtubules that ex-
hibit highly dynamic properties (Brown et al., 1993). More impor-
tantly, Phr1 seems to associate with microtubules, which appear
morphologically abnormal in Magellan mutants, presumably due
to an increased turnover.
PHR Effectors during Peripheral Axonogenesis
Like Phr1, DLK is also expressed in developing mouse motor and
sensory neurons. However, examination of protein localization
reveals that Phr1 and DLK accumulate in nonoverlapping sub-
cellular compartments. While Phr1 is mainly localized in the
axon, DLK is primarily distributed near the growth cone with
only low levels present in the axon shaft. In view of the proposed
functions of PHR proteins in downregulating DLK levels, these
observations suggest that murine Phr1 functions to restrict
DLK in the growth cone and eliminate it from the axon. Support-
ing this hypothesis, DLK protein is mislocalized in Magellan mu-
tant mice. In C. elegans, the effect of Rpm-1 on DLK is trans-
duced at the synapse by the p38 MAP kinase PMK-3. In Phr1
mice, antagonizing p38 activity with a pharmacological inhibitor
attenuates the microtubule phenotypes. This final result sug-
gests that murine p38 acts downstream of Phr1/DLK to mediate
microtubule dynamics in growth cones (Figure 2).
Conclusions
Synaptogenesis and axon guidance are highly specialized and
distinct aspects of neuronal cell biology that both rely on PHR
ubiquitin ligases to orchestrate complex cellular behavior. Al-
though it is likely that many PHR targets remain to be discovered,
the DLK family of kinases represents one important and well-
conserved theme in common between the synapse and the neu-
rite. The study by Lewcock and colleagues provides an attractive
model to explain how the cell polarity of neuronal processes can
be maintained through compartmental regulation of the same
MAP kinase signaling, where Phr1 defines a DLK-deficient
zone to promote the stability of microtubules and thus the
axon shaft. How this elegant machinery might contribute to
synaptic morphogenesis remains an intriguing question for the
future.
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